GCP
FBIO icon

GSA Capital Partners’s Fortress Biotech FBIO Stock Holding History

GSA Capital Partners’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.4M Buy
458,472
+204,338
+80% +$527K 0.09% 313
2026
Q1 		$709K Buy
254,134
+218,060
+604% +$741K 0.04% 693
2025
Q4 		$132K Buy
+36,074
New +$103K 0.01% 1498
2025
Q1 		– Sell
-60,474
Closed -$122K – 1780
2024
Q4 		$122K Sell
60,474
-21,300
-26% -$38.6K 0.01% 1499
2024
Q3 		$118K Sell
81,774
-113,505
-58% -$216K 0.01% 1476
2024
Q2 		$334K Buy
195,279
+88,003
+82% +$160K 0.02% 1209
2024
Q1 		$215K Buy
+107,276
New +$213K 0.02% 1380
2022
Q2 		– Sell
-13,574
Closed -$277K – 1510
2022
Q1 		$277K Buy
+13,574
New +$372K 0.04% 950
2021
Q4 		– Sell
-12,479
Closed -$603K – 1515
2021
Q3 		$603K Buy
12,479
+2,342
+23% +$114K 0.06% 587
2021
Q2 		$543K Buy
10,137
+5,454
+116% +$329K 0.06% 571
2021
Q1 		$248K Buy
4,683
+3,154
+206% +$178K 0.04% 768
2020
Q4 		$73K Buy
+1,529
New +$66.2K 0.01% 1122
2013
Q4 		– Sell
-1,270
Closed -$134K – 1669
2013
Q3 		$134K Buy
+1,270
New +$156K 0.01% 1464

Other funds holding FBIO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

GSA Capital Partners's FBIO Position: Q2 2026 in Review

GSA Capital Partners increased its Fortress Biotech (FBIO) stake by 80% in Q2 2026, buying an estimated $527K and bringing the position to 458,472 shares worth $1.4M. The position accounts for 0.09% of the portfolio, ranked #313.

GSA Capital Partners first reported a position in FBIO in Q3 2013 and has held it in 13 quarters since. 55 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.

  • GSA Capital Partners held 458,472 shares of Fortress Biotech worth $1.4M as of Q2 2026.
  • GSA Capital Partners bought 204,338 Fortress Biotech shares in Q2 2026, an estimated $527K.
  • Fortress Biotech made up 0.09% of GSA Capital Partners's portfolio in Q2 2026, its #313 holding.
  • GSA Capital Partners first reported a position in Fortress Biotech in Q3 2013 and has held it in 13 quarters since.
  • 55 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.